NCT07481305 Lifestyle Change Implementation Research Network at PRC at UMass Chan
| NCT ID | NCT07481305 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Massachusetts, Worcester |
| Condition | GLP - 1 |
| Study Type | INTERVENTIONAL |
| Enrollment | 220 participants |
| Start Date | 2026-07-22 |
| Primary Completion | 2029-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 220 participants in total. It began in 2026-07-22 with a primary completion date of 2029-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this project is to study how well the Noom digital lifestyle program works for adults who are taking Glucagon-Like Peptide-1 receptor agonist (GLP-1) medications. The study team will assess how the program affects people's behaviors and health outcomes. The team will also look at how digital lifestyle change interventions can be implemented in real-world settings, including how many people it reaches, how well it is put into practice, whether people stick with it over time, and whether it works well for different groups of people.
Eligibility Criteria
Inclusion Criteria: 1. Began using a GLP-1 within the past 6 months 2. Currently using GLP-1 3. Plans to continue GLP-1 use 4. GLP-1 prescribed by their physician (e.g., not online or 3rd party vendor) 5. BMI ≥27 kg/m2 6. Age 18 years of age and older 7. Speaks and reads English or Spanish 8. Willing to enroll in a digital lifestyle intervention for 4-months 9. Willing to wear a Fitbit for 8 months Exclusion Criteria: 1. Was taking a GLP-1 within the 2 months prior to the current GLP-1 start date 2. Currently participating in a structured lifestyle change program (receiving structured guidance and counseling on physical activity, diet or weight loss) 3. Currently pregnant 4. Planning to become pregnant in the next year 5. Active diagnosis of an eating disorder
Contact & Investigator
Jamie Faro, PhD
PRINCIPAL INVESTIGATOR
UMass Chan Medical School
Frequently Asked Questions
Who can join the NCT07481305 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying GLP - 1. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07481305 currently recruiting?
Yes, NCT07481305 is actively recruiting participants. Contact the research team at Reem.Najjar@umassmed.edu for enrollment information.
Where is the NCT07481305 trial being conducted?
This trial is being conducted at Worcester, United States.
Who is sponsoring the NCT07481305 clinical trial?
NCT07481305 is sponsored by University of Massachusetts, Worcester. The principal investigator is Jamie Faro, PhD at UMass Chan Medical School. The trial plans to enroll 220 participants.